-- 根據週二提交給香港交易所的文件，上海復星醫藥（SHA:600196，HKG:2196）公佈，2026年第一季歸屬於母公司股東的淨利潤同比增長14%，從去年同期的7.648億元增至8.708億元人民幣。 週三上午交易時段，該公司在香港的股價下跌近2%。 每股收益為0.33元人民幣，高於去年同期的0.29元。 數據顯示，營業收入成長近7%，達到101億元。
Related Articles
Asia
Veson's Controlling Shareholder Boosts Stake; Shares Jump 23%
Veson (HKG:1399) said its controlling shareholder, Fang Jin, increased his stake in the company, according to a Tuesday Hong Kong bourse filing.Shares of the firm were up nearly 23% in Wednesday afternoon trade.Fang, through a wholly owned private company Right Grand Holdings, purchased 34.7 million shares on April 24 via on- and off-market transactions, representing about 3.18% of the issued share capital.Following the purchase, Fang's interest rose to 587 million shares, or about 53.85%, from about 50.67% previously, the filing showed.
$HKG:1399
Asia
Crisil Affirms A Rating on Interarch Building Solutions' Bank Facilities; Outlook Stable
Crisil affirmed A long-term and A1 short-term rating on Interarch Building Solutions' (NSE:INTERARCH, BOM:544232) bank loan facilities, according to an Indian bourse filing on Wednesday.The rating outlook is stable, the filing said.
$BOM:544232$NSE:INTERARCH
Asia
Shreeji Shipping Global to Acquire Two Mini Bulk Carrier Vessels for INR557 Million
Shreeji Shipping Global (NSE:SHREEJISPG, BOM:544490) has agreed to acquire two mini bulk carrier vessels from Gautam Freight for 556.6 million Indian rupees, according to a filing to the Indian stock exchanges.The company will acquire the vessels, M.V. Gautam BSTAR II and M.V. Sanghi Sudarshan, as part of its fleet expansion, amounting to 8,810.80 deadweight tonnage.The vessels are scheduled to be delivered by May 1.The acquisition is expected to help boost the company's fleet utilization, optimize operating economics, and contribute positively to the company's revenue and profitability.
$BOM:544490$NSE:SHREEJISPG